ANUBISMED

Product NDC

83021-750

11-digit product format

830210750

Labeler code

83021

Product ID

83021-750_049f9ce0-73cc-2865-e063-6394a90a505a

Type

HUMAN OTC DRUG

Nonproprietary name

HA HYALURONIC

Dosage form

CREAM

Route

TOPICAL

Labeler

ANUBIS COSMETICS SL

Application

M016

Marketing category

OTC MONOGRAPH FINAL

Marketing start

2022-10-17

Marketing end

2028-01-16

Substance

ALLANTOIN; ALOE VERA LEAF; FRAGRANCE 13576; GLYCERYL MONOSTEARATE; TROLAMINE; BUTYLATED HYDROXYTOLUENE; PROPYLENE GLYCOL; CETYL ALCOHOL; TROPOLONE; TOCOPHEROL; DIMETHICONE; 1,2-HEXANEDIOL; IMIDUREA; CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; CETEARYL ETHYLHEXANOATE; MEDIUM-CHAIN TRIGLYCERIDES; CAPRYLYL GLYCOL; OCTINOXATE; GLYCERIN; GLYCERYL STEARATE SE; WATER; C12-20 ACID PEG-8 ESTER; OXYBENZONE; DECYL OLEATE

Active strength

.05; 2.5; .225; .875; .3; .0535; 1.996; .0038; .004; .0004; .25; .198; .15; .25; 1.75; 1.5; .198; 3.4965; .4975; 1.5; 27.4065; 2.25; 2; 1.9996 g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; mL/50mL; g/50mL; g/50mL; g/50mL

Pharmacologic classes

Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Skin Barrier Activity [PE], Standardized Chemical Allergen [EPC]

NDC exclude flag

No

Current FDA listing

Yes